thyroxine has been researched along with Non-alcoholic Fatty Liver Disease in 35 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Excerpt | Relevance | Reference |
---|---|---|
"The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear." | 8.12 | Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022) |
"Non-alcoholic fatty liver disease (NAFLD) has become a major public health problem concern in recent decades." | 5.72 | Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people. ( Cheng, Q; Shao, C; Xiang, X; Xu, Y; Zhang, S, 2022) |
"NAFLD was diagnosed by ultrasound." | 5.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
"NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD." | 5.46 | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017) |
"The relationship between FT4 and NAFLD in women was different according to menopausal status, with negative association in pre-menopausal women (OR: 0." | 5.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
" Hypothyroidism has been identified as a risk factor for NAFLD as thyroxine is required for regulating metabolism in adults." | 5.41 | Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. ( Li, L; Shi, Y; Song, Y; Sun, L, 2023) |
"Overweight/obesity mediated the associations of MAFLD with triiodothyronine (T3), free triiodothyronine (FT3), free thyroxine (FT4), and the mediator accounted for 46." | 4.31 | The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes. ( Cao, L; Chen, X; Fan, H; Li, L; Liu, Z; Suo, C; Zhang, T, 2023) |
"The association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear." | 4.12 | Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. ( Li, Z; Liu, HX; Ma, HJ; Meng, CQ; Nie, Q; Ren, YY; Yu, CH, 2022) |
" Based on their initial serum-free thyroxine (fT4) and thyroid-stimulating hormone (TSH) levels, they were classified into control, subclinical hypothyroidism (TSH >4." | 3.81 | Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study. ( Bang, KB; Cho, YK; Kwon, HJ; Lee, KW; Lee, MY; Rhee, EJ, 2015) |
"Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and associated with significant morbidity and mortality." | 2.87 | Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD. ( Angus, PW; Bee, YM; Bruinstroop, E; Burrell, LM; Cao, Y; Chandran, K; Cho, LW; Dalan, R; Leow, MKS; Leung, C; Lim, SC; Michael, N; Patel, SK; Sadananthan, SA; Sinha, RA; Soh, SB; Stapleton, HM; Sum, CF; Teo, EK; Toh, SA; Velan, SS; Yen, PM, 2018) |
"Non-alcoholic fatty liver disease (NAFLD) has become a major public health problem concern in recent decades." | 1.72 | Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people. ( Cheng, Q; Shao, C; Xiang, X; Xu, Y; Zhang, S, 2022) |
"In subjects with liver fibrosis, other cause of liver fibrosis were ruled out." | 1.72 | Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine. ( Arturi, F; Aversa, A; Brunetti, A; Mazza, E; Montalcini, T; Perticone, M; Pujia, A; Pujia, R; Romeo, S; Sciacqua, A, 2022) |
"In sufferers with nonalcoholic fatty liver disease (NAFLD), the differences of thyroid associated hormones and neutrophil to lymphocyte ratio (NLR) in different liver pathological groups have been compared." | 1.72 | Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease. ( Chu, W; Feng, J; Li, P; Liu, L; Liu, Y; Mi, Y; Niu, B; Wu, X; Zhang, P, 2022) |
"The incidence rate of NAFLD was 85." | 1.72 | High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. ( Gu, Y; Jia, Q; Liu, L; Meng, G; Niu, K; Song, K; Sun, S; Wang, X; Wang, Y; Wu, H; Wu, X; Zhang, Q; Zhang, S; Zhang, T; Zhou, M, 2022) |
"Thyroid function and type 2 diabetes mellitus (T2DM) are both associated with increased risks of adverse clinical outcomes in nonalcoholic fatty liver disease (NAFLD)." | 1.56 | Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. ( Huang, B; Yang, S; Ye, S, 2020) |
"Serum FT3 levels in subjects with NAFLD were significantly reduced, while TSH was increased compared to that in controls." | 1.56 | Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population. ( Dai, Y; Qin, J; Zhang, J; Zhang, X, 2020) |
"The major outcome was the occurrence of NAFLD, diagnosed based on the findings of abdominal ultrasonography." | 1.51 | The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. ( Chen, MY; Chen, SY; Chou, YY; Pan, YW; Tsai, MC; Yang, YJ, 2019) |
"NAFLD was diagnosed by ultrasound." | 1.51 | Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. ( Bao, Y; Chen, P; Feng, L; Hou, X; Jia, W; Jiao, L; Wang, H; Wei, L; Zhong, L, 2019) |
"In murine models of advanced nonalcoholic steatohepatitis (NASH), the administration of T3 reduced liver triglyceride, repressed liver inflammation, and attenuated injury." | 1.51 | Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis. ( Bechmann, L; Best, J; Canbay, A; Claridge, LC; Coombes, JD; Gerken, G; Manka, P; Moeller, L; Sydor, S; Syn, WK; Wedemeyer, H, 2019) |
"NAFLD was defined by using the validated Fatty Liver Index (FLI); FLI≥60 was categorized as NAFLD." | 1.46 | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. ( Amini, M; Blokzijl, H; Dullaart, RP; Faber, KN; Schreuder, TC; van den Berg, EH; van Tienhoven-Wind, LJ, 2017) |
"Hypothyroidism was considered at a thyroid stimulating hormone level ≥ 4." | 1.43 | FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. ( Ahbab, S; Ataoğlu, HE; Çetin, F; Gökmen, FY; Mamaç, RY; Türker, BÇ; Türker, F; Yenigün, M, 2016) |
"Subjects with NAFLD had significantly higher TSH levels and lower FT4 levels than those without NAFLD (p < 0." | 1.42 | Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. ( Gu, H; Sui, J; Tao, Y; Wu, J, 2015) |
"The relationship between FT4 and NAFLD in women was different according to menopausal status, with negative association in pre-menopausal women (OR: 0." | 1.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
"Non-alcoholic fatty liver disease (NAFLD) is one of the most common disorders of the liver worldwide." | 1.42 | Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. ( Boehm, BO; Denzer, C; Graeter, T; Greinert, A; Haenle, MM; Holzner, D; Koenig, W; Kratzer, W; Ludwig, U; Mason, RA; Oeztuerk, S, 2015) |
"NAFLD was diagnosed by conventional ultrasound examination." | 1.40 | Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. ( Aydın, S; Cesur, Y; Gökçe, S; Özgen, IT; Torun, E, 2014) |
"NAFLD and non-NAFLD groups had slightly higher fasting blood glucose values than the control group." | 1.40 | Thyroid function in obese children with non-alcoholic fatty liver disease. ( Bilgin, H; Pirgon, Ö, 2014) |
"NAFLD was significantly associated with hypothyroidism (30." | 1.38 | Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. ( Chung, GE; Kim, D; Kim, W; Kim, YJ; Lee, HS; Park, MJ; Yim, JY; Yoon, JH, 2012) |
"Patients with NAFLD had significantly lower levels of serum-free thyroxine (FT4) than controls (11·12 ± 1·43 vs 11·58 ± 1·47 pmol/l; P < 0·001)." | 1.37 | Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 19 (54.29) | 24.3611 |
2020's | 16 (45.71) | 2.80 |
Authors | Studies |
---|---|
Shao, C | 1 |
Cheng, Q | 1 |
Zhang, S | 2 |
Xiang, X | 2 |
Xu, Y | 2 |
Zhang, Y | 5 |
Li, J | 1 |
Liu, H | 1 |
Fan, H | 2 |
Liu, Z | 2 |
Zhang, X | 5 |
Wu, S | 1 |
Shi, T | 1 |
Zhang, P | 2 |
Chen, X | 3 |
Zhang, T | 3 |
Pujia, R | 1 |
Mazza, E | 1 |
Montalcini, T | 1 |
Arturi, F | 1 |
Brunetti, A | 1 |
Aversa, A | 1 |
Romeo, S | 1 |
Perticone, M | 1 |
Sciacqua, A | 1 |
Pujia, A | 1 |
Liu, HX | 1 |
Ren, YY | 1 |
Meng, CQ | 1 |
Li, Z | 2 |
Nie, Q | 1 |
Yu, CH | 1 |
Ma, HJ | 1 |
Li, L | 3 |
Cao, L | 1 |
Suo, C | 1 |
Li, P | 1 |
Liu, L | 4 |
Niu, B | 1 |
Mi, Y | 1 |
Liu, Y | 1 |
Feng, J | 1 |
Wu, X | 2 |
Chu, W | 1 |
Chen, YL | 1 |
Tian, S | 1 |
Wu, J | 3 |
Li, H | 3 |
Li, S | 1 |
Xu, Z | 2 |
Liang, XY | 1 |
Adhikari, VP | 1 |
Xiao, J | 1 |
Song, JY | 1 |
Ma, CY | 1 |
She, RL | 1 |
Li, ZX | 1 |
Wu, KN | 1 |
Kong, LQ | 1 |
Song, Y | 1 |
Shi, Y | 1 |
Sun, L | 1 |
Hu, Y | 1 |
Zhou, F | 1 |
Lei, F | 1 |
Lin, L | 1 |
Huang, X | 1 |
Sun, T | 1 |
Liu, W | 1 |
Cai, J | 1 |
She, ZG | 1 |
Wan, H | 1 |
Yu, G | 1 |
Xu, S | 1 |
Jiang, Y | 1 |
Duan, H | 1 |
Lin, X | 1 |
Ma, Q | 1 |
Wang, D | 1 |
Liang, Y | 1 |
Shen, J | 1 |
Nikolaou, M | 1 |
Vasilakis, IA | 1 |
Marinakis, NM | 1 |
Tilemis, FN | 1 |
Zellos, A | 1 |
Lykopoulou, E | 1 |
Traeger-Synodinos, J | 1 |
Kanaka-Gantenbein, C | 1 |
Pan, YW | 1 |
Tsai, MC | 1 |
Yang, YJ | 1 |
Chen, MY | 1 |
Chen, SY | 1 |
Chou, YY | 1 |
Huang, B | 1 |
Yang, S | 1 |
Ye, S | 1 |
Zhang, J | 2 |
Dai, Y | 1 |
Qin, J | 1 |
Gu, Y | 1 |
Zhang, Q | 2 |
Meng, G | 1 |
Wu, H | 1 |
Wang, Y | 4 |
Wang, X | 2 |
Sun, S | 1 |
Zhou, M | 1 |
Jia, Q | 1 |
Song, K | 1 |
Niu, K | 1 |
Quirós-González, V | 1 |
Rubio, R | 1 |
Pulido, F | 1 |
Rial-Crestelo, D | 1 |
Martín-Jurado, C | 1 |
Hernández-Ros, MÁ | 1 |
López-Jiménez, EA | 1 |
Ferrari, JM | 1 |
Caro-Teller, JM | 1 |
Pinar, Ó | 1 |
Pedrera-Jiménez, M | 1 |
García-Barrio, N | 1 |
Serrano, P | 1 |
Bernal, JL | 1 |
Tanguay, P | 1 |
Décary, S | 1 |
Martineau-Roy, J | 1 |
Gravel, EM | 1 |
Gervais, I | 1 |
St-Jean, P | 1 |
Tousignant, M | 1 |
Marquis, N | 1 |
Qian, L | 1 |
Xuemei, L | 1 |
Jitao, L | 1 |
Yun'Ai, S | 1 |
Tianmei, S | 1 |
da Silva, HS | 1 |
Nakamura, FY | 1 |
Papoti, M | 1 |
da Silva, AS | 1 |
Dos-Santos, JW | 1 |
Huth, SF | 1 |
Cho, SM | 1 |
Robba, C | 1 |
Highton, D | 1 |
Battaglini, D | 1 |
Bellapart, J | 1 |
Suen, JY | 1 |
Li Bassi, G | 1 |
Taccone, FS | 1 |
Arora, RC | 1 |
Whitman, G | 1 |
Fraser, JF | 1 |
Fanning, JP | 1 |
Yang, B | 1 |
Dmytriw, AA | 1 |
Wang, T | 1 |
Luo, J | 1 |
Li, Y | 2 |
Ma, Y | 1 |
Chen, J | 1 |
Gao, P | 1 |
Feng, Y | 1 |
Bai, X | 1 |
Dong, J | 1 |
Yang, R | 1 |
Jiao, L | 2 |
Ling, F | 1 |
Ding, Y | 1 |
Chen, Z | 1 |
Pan, Y | 1 |
Wang, J | 1 |
Meng, X | 1 |
Lin, J | 1 |
Jing, J | 1 |
Xie, X | 1 |
Lwi, SJ | 1 |
Herron, TJ | 1 |
Curran, BC | 1 |
Ivanova, MV | 1 |
Schendel, K | 1 |
Dronkers, NF | 1 |
Baldo, JV | 1 |
Yi, X | 1 |
Yang, Y | 1 |
Zhao, Z | 2 |
Xu, M | 1 |
Sheng, Y | 1 |
Tian, J | 1 |
Hua, W | 1 |
Peng, Y | 1 |
Han, Z | 1 |
Li, T | 2 |
Yin, C | 1 |
Wang, S | 1 |
Nan, G | 1 |
Yang, H | 1 |
Zhou, B | 1 |
Cai, Y | 1 |
Li, G | 1 |
Peng, X | 1 |
Guan, S | 1 |
Zhou, J | 1 |
Ye, M | 1 |
Wang, L | 1 |
Zhang, L | 1 |
Hong, B | 1 |
Wan, J | 1 |
Zhu, Q | 1 |
Liu, J | 1 |
Yang, P | 1 |
Guido, CA | 1 |
Loffredo, L | 1 |
Zicari, AM | 1 |
Pavone, P | 1 |
Savasta, S | 1 |
Gagliano, A | 1 |
Brindisi, G | 1 |
Galardini, G | 1 |
Bertolini, A | 1 |
Spalice, A | 1 |
Zheng, S | 1 |
Wang, H | 2 |
Chen, G | 1 |
Shangguan, H | 1 |
Yu, L | 1 |
Lin, Z | 1 |
Lin, Y | 1 |
Yao, P | 1 |
Kang, D | 1 |
Guo, W | 1 |
Qin, P | 1 |
Li, XN | 1 |
Lu, J | 1 |
Zhu, WF | 1 |
Diao, QQ | 1 |
Xu, NZ | 1 |
Machlab, S | 1 |
Miquel, M | 1 |
Voltà, T | 1 |
Escoda, MR | 1 |
Vergara, M | 1 |
Bruinstroop, E | 1 |
Dalan, R | 1 |
Cao, Y | 1 |
Bee, YM | 1 |
Chandran, K | 1 |
Cho, LW | 1 |
Soh, SB | 1 |
Teo, EK | 1 |
Toh, SA | 1 |
Leow, MKS | 1 |
Sinha, RA | 1 |
Sadananthan, SA | 1 |
Michael, N | 1 |
Stapleton, HM | 1 |
Leung, C | 1 |
Angus, PW | 1 |
Patel, SK | 1 |
Burrell, LM | 1 |
Lim, SC | 1 |
Sum, CF | 1 |
Velan, SS | 1 |
Yen, PM | 1 |
Chen, P | 1 |
Hou, X | 1 |
Wei, L | 1 |
Feng, L | 1 |
Zhong, L | 1 |
Bao, Y | 1 |
Jia, W | 1 |
Patel, VJ | 1 |
Joharapurkar, AA | 1 |
Kshirsagar, SG | 1 |
Sutariya, BK | 1 |
Patel, MS | 1 |
Bahekar, RH | 1 |
Jain, MR | 1 |
Manka, P | 1 |
Bechmann, L | 1 |
Best, J | 1 |
Sydor, S | 1 |
Claridge, LC | 1 |
Coombes, JD | 1 |
Canbay, A | 1 |
Moeller, L | 1 |
Gerken, G | 1 |
Wedemeyer, H | 1 |
Syn, WK | 1 |
Torun, E | 1 |
Özgen, IT | 1 |
Gökçe, S | 1 |
Aydın, S | 1 |
Cesur, Y | 1 |
Bilgin, H | 1 |
Pirgon, Ö | 1 |
Tao, Y | 1 |
Gu, H | 1 |
Sui, J | 1 |
Liu, G | 1 |
Zheng, X | 1 |
Guan, L | 1 |
Jiang, Z | 1 |
Lin, H | 1 |
Jiang, Q | 1 |
Zhang, N | 1 |
Yu, C | 2 |
Guan, Q | 1 |
van Tienhoven-Wind, LJ | 2 |
Dullaart, RP | 2 |
Ludwig, U | 1 |
Holzner, D | 1 |
Denzer, C | 1 |
Greinert, A | 1 |
Haenle, MM | 1 |
Oeztuerk, S | 1 |
Koenig, W | 1 |
Boehm, BO | 1 |
Mason, RA | 1 |
Kratzer, W | 1 |
Graeter, T | 1 |
Lee, KW | 1 |
Bang, KB | 1 |
Rhee, EJ | 1 |
Kwon, HJ | 1 |
Lee, MY | 1 |
Cho, YK | 1 |
Gökmen, FY | 1 |
Ahbab, S | 1 |
Ataoğlu, HE | 1 |
Türker, BÇ | 1 |
Çetin, F | 1 |
Türker, F | 1 |
Mamaç, RY | 1 |
Yenigün, M | 1 |
Geach, T | 1 |
van den Berg, EH | 1 |
Amini, M | 1 |
Schreuder, TC | 1 |
Faber, KN | 1 |
Blokzijl, H | 1 |
Xu, C | 1 |
Xu, L | 1 |
Miao, M | 1 |
Walsh, JP | 1 |
Chung, GE | 1 |
Kim, D | 1 |
Kim, W | 1 |
Yim, JY | 1 |
Park, MJ | 1 |
Kim, YJ | 1 |
Yoon, JH | 1 |
Lee, HS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients[NCT03281083] | Phase 2 | 29 participants (Actual) | Interventional | 2014-03-28 | Terminated (stopped due to Difficult recruitment and end of funding.) | ||
Early Predictors of NAFLD in Patient of Hypothyroidism[NCT05813301] | 100 participants (Anticipated) | Observational | 2023-11-01 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for thyroxine and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.
Topics: Animals; Humans; Hypothyroidism; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Thyroid Hormone | 2023 |
Hepatomegaly and fatty liver disease secondary to central hypothyroidism in combination with macrosomia as initial presentation of IGSF1 deficiency syndrome.
Topics: Adult; Congenital Hypothyroidism; Female; Fetal Macrosomia; Hepatomegaly; Humans; Immunoglobulins; I | 2023 |
Topics: Adult; China; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver D | 2023 |
Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders.
Topics: Asymptomatic Diseases; Cardiovascular Diseases; Cholesterol, LDL; Humans; Hypothyroidism; Insulin Re | 2015 |
1 trial available for thyroxine and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD.
Topics: Adult; Diabetes Mellitus, Type 2; Humans; Lipids; Liver; Male; Middle Aged; Non-alcoholic Fatty Live | 2018 |
30 other studies available for thyroxine and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people.
Topics: Cross-Sectional Studies; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Retrospective Stud | 2022 |
Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function.
Topics: Diabetes Mellitus, Type 2; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Retrospective | 2022 |
Thyroid Stimulating Hormone Levels Are Associated With Genetically Predicted Nonalcoholic Fatty Liver Disease.
Topics: Humans; Mendelian Randomization Analysis; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; Thyr | 2022 |
Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine.
Topics: Cross-Sectional Studies; Humans; Hypothyroidism; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver D | 2022 |
Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population.
Topics: Adiposity; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors; Thyroxi | 2022 |
The association between thyroid hormones and MAFLD is mediated by obesity and metabolic disorders and varies among MAFLD subtypes.
Topics: Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thyroid Hormones | 2023 |
Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease.
Topics: Fibrosis; Humans; Lymphocytes; Neutrophils; Non-alcoholic Fatty Liver Disease; Thyroid Gland; Thyroi | 2022 |
Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease.
Topics: Cardiovascular Diseases; Humans; Hypothyroidism; Non-alcoholic Fatty Liver Disease; Nutrition Survey | 2023 |
The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease.
Topics: Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Thyroid G | 2023 |
Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults.
Topics: Adult; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Prospective Studies; Risk Factors | 2023 |
The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients.
Topics: Adolescent; Adult; Blood Glucose; Child; Congenital Hypothyroidism; Cross-Sectional Studies; Female; | 2019 |
Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-a | 2020 |
Serum Thyroid Hormones Levels are Significantly Associated with Nonalcoholic Fatty Liver Disease in Euthyroid Chinese Population.
Topics: China; Cross-Sectional Studies; Humans; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Ri | 2020 |
High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects.
Topics: Aged; Cohort Studies; Humans; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; T | 2022 |
Turner syndrome as a cause of liver cirrhosis.
Topics: Estrogens; Female; Gilbert Disease; Hashimoto Disease; Hormone Replacement Therapy; Human Growth Hor | 2018 |
Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women.
Topics: Alanine Transaminase; Cross-Sectional Studies; Disease Progression; Female; Humans; Liver Cirrhosis, | 2019 |
Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.
Topics: Animals; Bile; Diet, High-Fat; Glucagon-Like Peptide 1; Liver; Male; Methimazole; Mice; Mice, Inbred | 2019 |
Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
Topics: Biomarkers; Down-Regulation; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty | 2019 |
Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
Topics: Adolescent; Anthropometry; Biomarkers; Case-Control Studies; Child; Fatty Liver; Female; Follow-Up S | 2014 |
Thyroid function in obese children with non-alcoholic fatty liver disease.
Topics: Adolescent; Biomarkers; Blood Glucose; Case-Control Studies; Child; Female; Humans; Insulin; Insulin | 2014 |
Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic | 2015 |
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.
Topics: Adult; China; Comorbidity; Female; Humans; Male; Menopause; Metabolic Syndrome; Middle Aged; Non-alc | 2015 |
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cross-Secti | 2015 |
Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
Topics: Adult; Aged; Cohort Studies; Female; Follow-Up Studies; Humans; Hypothyroidism; Incidence; Kaplan-Me | 2015 |
FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.
Topics: Adult; Biomarkers; Cholesterol; Female; Humans; Hypothyroidism; Insulin Resistance; Male; Metabolic | 2016 |
Thyroid function: Poor thyroid function linked to NAFLD.
Topics: Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Thyroid Function Tests; Thyroid Gland; Thyro | 2016 |
Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Female; Humans; | 2017 |
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.
Topics: Aged; Asian People; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Humans; Non-alcoholic Fat | 2011 |
Setpoints and susceptibility: do small differences in thyroid function really matter?
Topics: Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Thyroid Gland; Thyroxine | 2011 |
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.
Topics: Adult; Alanine Transaminase; Body Mass Index; Cross-Sectional Studies; Fatty Liver; Female; Humans; | 2012 |